Barclays’s EndoChoice Holdings, Inc. GI Stock Holding History

Barclays’s Portfolio GI Stock Details GI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,935	Closed	-$64K	–	7072
2016 Q3	$64K	Buy	7,935 +638	+9%	+$2.99K	﹤0.01%	4841
2016 Q2	$36K	Buy	7,297 +508	+7%	+$2.42K	﹤0.01%	5017
2016 Q1	$34K	Buy	6,789 +54	+0.8%	+$296	﹤0.01%	4993
2015 Q4	$54K	Hold	6,735	–	–	﹤0.01%	4753
2015 Q3	$74K	Buy	6,735 +1,635	+32%	+$25.6K	﹤0.01%	4799
2015 Q2	$82K	Buy	+5,100	New	+$84.7K	﹤0.01%	4816

Barclays's GI Position: Q4 2016 in Review

Barclays sold out of EndoChoice Holdings, Inc. (GI) in Q4 2016, closing a stake of 7,935 shares — an estimated $64K sold.

Barclays first reported a position in GI in Q2 2015 and held it in 6 quarters. The position peaked at $82K in Q2 2015. 0 funds tracked by Wall St. Rank hold GI as of Q4 2016.

Barclays reported no remaining EndoChoice Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
Barclays sold 7,935 EndoChoice Holdings, Inc. shares in Q4 2016, an estimated $64K.
Barclays first reported a position in EndoChoice Holdings, Inc. in Q2 2015 and held it in 6 quarters.
Barclays's EndoChoice Holdings, Inc. position peaked at $82K in Q2 2015.
0 funds tracked by Wall St. Rank held EndoChoice Holdings, Inc. as of Q4 2016.

Based on Barclays's 13F filing for Q4 2016, filed 14 Feb 2017.